NovelStem International Corp.
NSTM · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.01 | 0.00 | -0.00 |
| FCF Yield | -4.75% | -11.10% | -10.73% | -3.34% |
| EV / EBITDA | 1.13 | -52.79 | -2.77 | -9.04 |
| Quality | ||||
| ROIC | 29.26% | 12.77% | 5.93% | 5,395.96% |
| Gross Margin | 0.00% | 0.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 0.00 | -0.02 | 0.21 | 0.24 |
| Growth | ||||
| Revenue 3-Year CAGR | -47.72% | -20.63% | -9.14% | -0.00% |
| Free Cash Flow Growth | -52.86% | -11.42% | 37.30% | 35.72% |
| Safety | ||||
| Net Debt / EBITDA | 0.63 | -48.62 | -2.55 | -6.28 |
| Interest Coverage | -1.25 | -0.84 | -0.36 | -5.35 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 315.00 | 225.00 |